Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

Dixon, John B., Bhathal, Prithi S., Hughes, Norman R., O'Brien, Paul E.·2004·Hepatology
DOI 10.1002/hep.20251

Cited by (725)

Items 401–500 of 725

  1. Future therapy of portal hypertension in liver cirrhosis – a guess
    Tilman Sauerbruch, Jonel Trebicka · 2014 · F1000Prime Reports
  2. The Effect of Bariatric Surgery on the Spectrum of Fatty Liver Disease
    Jordan J. Nostedt, Noah Jacob Switzer, Richdeep S. Gill, Jerry T. Dang, Daniel W. Birch, Christopher de Gara, Robert James Bailey, Shahzeer Karmali · 2016 · Canadian Journal of Gastroenterology and Hepatology
  3. Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1/AMPKα pathway
    Tian Shen, Bilin Xu, Tao Lei, Lin Chen, Cuiping Zhang, Zhenhua Ni · 2018 · Experimental and Therapeutic Medicine
  4. Citation classics: Top 50 cited articles in bariatric and metabolic surgery
    Ali Aminian, Christopher Ryan Daigle, Stacy A. Brethauer, Philip R. Schauer · 2014 · Surgery for Obesity and Related Diseases
  5. Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease
    Helena Cortez‐Pinto, Mariana Verdelho Machado · 2008 · Expert Review of Gastroenterology & Hepatology
  6. Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis
    Åsa Danielsson Borssén, Richard Palmqvist, Stergios Kechagias, Hanns–Ulrich Marschall, Annika M Bergquist, Fredrik Rorsman, Ola Weiland, Hans Verbaan, Nils Nyhlin, Emma Nilsson et al. · 2017 · Medicine
  7. Obstetrician-Gynecologists' Strategies for Patient Initiation and Maintenance of Antiobesity Treatment with Glucagon-Like Peptide-1 Receptor Agonists
    Lisa A. Gill, Suzanne Mackey · 2021 · Journal of Women s Health
  8. Effect modification of body mass index and body fat percentage on fatty liver disease in a J apanese population
    智美 才田, Wakaba Fukushima, Satoko Ohfuji, Kyoko Kondo, Ichiro Matsunaga, Yoshio Hirota · 2013 · Journal of Gastroenterology and Hepatology
  9. The combined effect of alcohol and body mass index on risk of chronic liver disease: A systematic review and meta‐analysis of cohort studies
    Kate Glyn‐Owen, Dankmar Böhning, Julie Parkes, Paul J. Roderick, Ryan Malcolm Buchanan · 2020 · Liver International
  10. Alanine Amino Transferase Concentrations Are Linked to Folate Intakes and Methylenetetrahydrofolate Reductase Polymorphism in Obese Adolescent Girls
    Marie‐Laure Frelut, Nathalie Fillon-Emery, Jean-Claude Guilland, H H Dao, G. Potier de Courcy · 2006 · Journal of Pediatric Gastroenterology and Nutrition
  11. Nonalcoholic Steatohepatitis: Clinical Presentation, Diagnosis, and Treatment.
    Joel Z. Stengel, Stephen A. Harrison · 2006 · Europe PMC (PubMed Central)
  12. The pivotal role of heme Oxygenase-1 in reversing the pathophysiology and systemic complications of NAFLD
    Ariel Sasson, Eva Kristoferson, Rogério Oliveira Batista, John Arthur McClung, Nader G. Abraham, Stephen J. Peterson · 2020 · Archives of Biochemistry and Biophysics
  13. Nonalcoholic Steatohepatitis: A Review of the Literature and Updates in Management
    Lakshmi Pasumarthy, James W. Srour · 2010 · Southern Medical Journal
  14. Air pollution, weight loss and metabolic benefits of bariatric surgery: a potential model for study of metabolic effects of environmental exposures
    R. Ghosh, W. James Gauderman, Hilary A. Minor, Heekoung Allison Youn, Fredrick W. Lurmann, Kevin R. Cromar, Leda Chatzi, Britni R. Belcher, C. R. Fielding, Rob McConnell · 2017 · Pediatric Obesity
  15. Nonalcoholic Fatty Liver Disease
    Lingling Ding, Yvonne Oligschlaeger, Ronit Shiri‐Sverdlov, Tom Houben · 2020 · Handbook of experimental pharmacology
  16. The effect of very low-calorie diets on renal and hepatic outcomes: a systematic review
    Catherine Rolland, Alexandra Mavroeidi, Kelly L. Johnston, John I Broom · 2013 · Diabetes Metabolic Syndrome and Obesity
  17. New treatments for nonalcoholic fatty liver disease
    Stephen A. Harrison · 2006 · Current Gastroenterology Reports
  18. Understanding MASH: An Examination of Progression and Clinical Outcomes by Disease Severity in the TARGET-NASH Database
    Rakesh Luthra, Aarth Sheth · 2024 · Advances in Therapy
  19. Non-alcoholic fatty liver disease
    Michael Pavlides, Jeremy Cobbold · 2015 · Medicine
  20. Non-alcoholic fatty liver disease
    Neeraj B. Bhala, Timothy Usherwood, Jacob George · 2009 · BMJ
  21. A 12-week aerobic exercise program without energy restriction improves intrahepatic fat, liver function and atherosclerosis-related factors
    Eiichi Yoshimura, Hideaki Kumahara, Takuro Tobina, Makoto Ayabe, Sakiko Matono, Keizo Anzai, Yasuki Higaki, Akira Kiyonaga, Hiroaki Tanaka · 2011 · Obesity Research & Clinical Practice
  22. Nonalcoholic Fatty Liver Disease and Diabetes Mellitus
    Leon Anton Adams · 2007 · Endocrine Research
  23. Correlations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidity
    Charles H. C. Pilgrim, Laveniya Satgunaseelan, Alan Pham, William K. Murray, Emma K. Link, Marty Smith, Val Usatoff, Peter M. Evans, Simon Banting, Benjamin N. J. Thomson et al. · 2012 · HPB
  24. Chinese Herbal Formula (CHF03) Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) Through Inhibiting Lipogenesis and Anti-Oxidation Mechanisms
    Yizhe Cui, Renxu Chang, Tao Zhang, Xiaocui Zhou, Qiuju Wang, Haiyun Gao, Lintong Hou, Juan J. Loor, Chuang Xu · 2019 · Frontiers in Pharmacology
  25. Should patients with type 2 diabetes and raised liver enzymes be referred for further evaluation of liver disease?
    Ingrid J. Hickman, Anthony William Russell, Johannes B. Prins, Graeme A. Macdonald · 2008 · Diabetes Research and Clinical Practice
  26. Fatty liver in the intensive care unit
    Nicolas Paquot, Jean Delwaide · 2005 · Current Opinion in Clinical Nutrition & Metabolic Care
  27. Intermittent Fasting Alleviates Non‐Alcoholic Steatohepatitis by Regulating Bile Acid Metabolism and Promoting Fecal Bile Acid Excretion in High‐Fat and High‐Cholesterol Diet Fed Mice
    Xiaozhuan Lin, Xuan Zhu, Yan Xin, Peiwen Zhang, Yunjun Xiao, Taiping He, Honghui Guo · 2023 · Molecular Nutrition & Food Research
  28. Quantification of Hepatic Fat and Iron with Magnetic Resonance Imaging
    Shane A. Wells · 2014 · Magnetic Resonance Imaging Clinics of North America
  29. Hepatic steatosis and reduction in steatosis following bariatric weight loss surgery differs between segments and lobes
    Soudabeh Fazeli Dehkordy, Kathryn Jane Fowler, Adrija Mamidipalli, Tanya J. Wolfson, Cheng William Hong, Yesenia Covarrubias, Jonathan C. Hooker, Ethan Z. Sy, Alexandra N. Schlein, Jennifer Y. Cui et al. · 2018 · European Radiology
  30. Impact of Nutrition and Obesity on Chronic Liver Disease
    Vignan Manne, Sammy Saab · 2013 · Clinics in Liver Disease
  31. The effect of bariatric surgeries on nonalcoholic fatty liver disease
    Mazen M. Hassanain, Amnah Al-Mulhim, Atheer Al-Sabhan, Shaden Al-Amro, Fahad Y. Bamehriz, Ayman A. Abdo, Hisham Al Khalidi · 2014 · Saudi Journal of Gastroenterology
  32. Electrical and optical spectroscopy for quantitative screening of hepatic steatosis in donor livers
    B L McLaughlin, Antonia C. Wells, Sam Virtue, Antonio Vidal‐Puig, Timothy D. Wilkinson, Christopher J.E. Watson, P A Robertson · 2010 · Physics in Medicine and Biology
  33. The GLP-1 Receptor Agonist Dulaglutide Attenuates Hepatic Steatosis in Obesity via a Weight-Independent Mechanism
    Dharti Shantaram, Xilal Y. Rima, David P. Bradley, Joey Z. Liu, Valerie P. Wright, ANASTASIIA AMARI, Anahita Jalilvand, Joseph Rottinghaus, Jaden M. Fernandes, Alan J. Smith et al. · 2025 · Diabetes
  34. SILAC‐based quantitative proteomic analysis of secretome between activated and reverted hepatic stellate cells
    Hongyu Zhang, Peng Wu, Fangyan Chen, Yunwei Hao, Yuanxiang Lao, Liangliang Ren, Longqin Sun, Wei Sun, Handong Wei, Daniel W. Chan et al. · 2014 · PROTEOMICS
  35. Liver Failure and Liver Disease
    Elwyn Elias · 2006 · Hepatology
  36. Hepatitis B and End-Stage Liver Disease
    Ilan S. Weisberg, Robert S. Brown, Samuel Harold Sigal · 2007 · Clinics in Liver Disease
  37. Morbid obesity, nonalcoholic fatty liver disease, and weight loss surgery†
    Savita Srivastava, Zobair M. Younossi, Hartmut Jaeschke, Kevin D. Mullen, Darius Moradpour · 2005 · Hepatology
  38. Surgical Management of Obesity in Patients with Morbid Obesity and Nonalcoholic Fatty Liver Disease
    John B. Dixon · 2013 · Clinics in Liver Disease
  39. Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents
    Hiroyasu Sakai · 2015 · World Journal of Gastroenterology
  40. Bariatric surgery during the evolution of fatty liver–A randomized clinical trial comparing gastric bypass and sleeve gastrectomy based on transient elastography
    Fernando de BARROS, Ana Beatriz Monteiro Fonseca · 2020 · Clinical Obesity
  41. The Impact of Weight Changes on Nonalcoholic Fatty Liver Disease in Adult Men with Normal Weight
    Ji‐Young Cho, Tae‐Heum Chung, Kyoung-Mo Lim, Hee-Jin Park, Jung-Mi Jang · 2014 · Korean Journal of Family Medicine
  42. Nonalcoholic Fatty Liver Disease of Obesity
    M. Sachdev, C. Riely, A. Madan · 2006 · Obesity Surgery
  43. 233 Bariatric Surgery Improves Histological Features of Nonalcoholic Fatty Liver Disease and Liver Fibrosis
    Andrew A. Taitano, Michael Markow, Jon E. Finan, Donald E. Wheeler, John Paul Gonzalvo, Michel M. Murr · 2014 · Gastroenterology
  44. Nutrition in pathophysiology and treatment of nonalcoholic fatty liver disease
    Alexander Rupert Moschen, Herbert Tilg · 2008 · Current Opinion in Clinical Nutrition & Metabolic Care
  45. Therapeutic approaches for non-alcoholic steatohepatitis
    Luc F. Van Gaal, Jonathan Mertens, Sven Francque, Christophe E.M. De Block · 2021 · Therapeutic Advances in Endocrinology and Metabolism
  46. Non-alcoholic steatohepatitis
    Brent A. Neuschwander‐Tetri · 2006 · Current Opinion in Endocrinology & Diabetes
  47. Liver failure in an obese middle-aged woman after biliointestinal bypass
    Dolores Sgambato · 2013 · World Journal of Clinical Cases
  48. Obesity
    Samuel Klein, Johannes Anthonius Romijn · 2016 · Elsevier eBooks
  49. Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors
    Jake Peter Mann, Paul Carter, Matthew James Armstrong, Hesham K. Abdelaziz, Hardeep Uppal, Billal Patel, SURESH RAMA CHANDRAN, Ranjit S More, Philip Noel Newsome, Rahul Potluri · 2020 · PLoS ONE
  50. Changes in serum albumin and liver enzymes following three different types of bariatric surgery: six-month follow-up. A retrospective cohort study
    Zadeh, Mohadeseh Hassan, Zamaninour, Negar, Ansar, Hastimansooreh, Kabir, Ali, Pazouki, Abdolreza, Farsani, Gholamreza Mohammadi · 2021 · Sao Paulo Medical Journal
  51. The vitamin E reduces liver lipoperoxidation and fibrosis in a model of nonalcoholic steatohepatitis
    Idilio Zamin, Ângelo Alves de Mattos, Ângelo Zambam de Mattos, Gabriela Perdomo Coral, Diogo Edele dos Santos, Cláudia Ramos Rhoden · 2010 · Arquivos de Gastroenterologia
  52. Antagonism of central melanin-concentrating hormone 1 receptor alleviates steatohepatitis in mice
    Makoto Ito, Akira Gomori, Jun Suzuki, Shigeharu Tsujioka, Minoru Sasaki, Masao Matsuda, Maria A. Bednarek, Masahiko Ito, Akane Ishihara, Hisashi Iwaasa et al. · 2008 · Journal of Endocrinology
  53. Efficacy of the Omega-3 Index in predicting non-alcoholic fatty liver disease in overweight and obese adults: a pilot study
    Helen M. Parker, Helen T O'Connor, Shelley Elizabeth Keating, Jeffrey S. Cohn, Manohar L. Garg, Ian Douglas Caterson, Jacob George, Nathan Anthony Johnson · 2015 · British Journal Of Nutrition
  54. Is a bariatric procedure appropriate in patients with portal hypertension secondary to cirrhosis?
    Michael G. Sarr · 2006 · Surgery for Obesity and Related Diseases
  55. Pathology of fatty liver: differential diagnosis of non-alcoholic fatty liver disease
    Matthew M. Yeh, Elizabeth M. Brunt · 2008 · Diagnostic histopathology
  56. Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis
    Francesco Angelico, Cristiano Alessandri, Marco Burattin, Maria Del Ben, Serena Orando, Flavio Lirussi · 2005
  57. The future liver of the Asia pacific: fatter and firmer from more fructose and fortune?
    S. Mahady, J. George · 2013 · Journal of Clinical and Experimental Hepatology
  58. Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance
    Vincenza Calvaruso, Vito Di Marco, Donatella Ferraro, Salvatore Petta, Anna Calì, Maria Grazia Bavetta, Elisabetta Conte, Piero Luigi Almasio · 2013 · Hepatitis Monthly
  59. Non‐alcoholic fatty liver disease: Confronting the global epidemic requires better awareness
    H Janaka de Silva, Anuradha Supun Dassanayake · 2009 · Journal of Gastroenterology and Hepatology
  60. [Nonalcoholic fatty liver disease: clinical and histological characteristics in obese who underwent bariatric surgery].
    Almir Galvão Vieira Bitencourt, Helma Pinchemel Cotrim, Erivaldo Santos Alves, Alessandro Moura de Almeida, Daniel Batista Valente Barbosa, Adiméia Souza Santos, Ana Piedade Lobo, Luciana G. M. de Athayde, Adriano Rios, Mariana Carvalho Gouveia et al. · 2007 · PubMed
  61. Laparoscopic Surgery’s 100 Most Influential Manuscripts: A Bibliometric Analysis
    Katie Mellor, Arfon G. M. T. Powell, Wyn Griffith Lewis · 2018 · Surgical Laparoscopy Endoscopy & Percutaneous Techniques
  62. Effect of Sinai San decoction on the development of non-alcoholic steatohepatitis in rats
    Qi Zhang · 2005 · World Journal of Gastroenterology
  63. Nonalcoholic steatohepatitis: Pathogenesis and treatment
    Sang Hoon Park · 2008 · The Korean Journal of Hepatology
  64. Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review
    Tasabehji, Dana, Saleh, Sanaz, Mokadem, Mohamad · 2025 · Journal of Clinical Medicine
  65. Physical Activity is Related to Fatty Liver Marker in Obese Youth, Independently of Central Obesity or Cardiorespiratory Fitness.
    Clarice Martins, Luísa Aires, Ismael Forte Freitas Júnior, Gustavo Silva, Alexandre Sérgio Silva, Luís Lemos, Jorge Augusto Pinto Silva Mota · 2015 · PubMed Central
  66. Does bariatric surgery reduce the severity of NAFLD?
    Helma Pinchemel Cotrim, Carla Daltro · 2010 · Nature Reviews Gastroenterology & Hepatology
  67. Spectrum of histological features in non-alcoholic fatty liver disease.
    Nandini Vasdev, Anjali G Kakati, Sanjiv Saigal, Nabeen Chandra Nayak · 2007 · PubMed
  68. Fatty Liver Disease
    Elizabeth M. Brunt, DINA G. TINIAKOS · 2009 · Elsevier eBooks
  69. Rise of sodium-glucose cotransporter 2 inhibitors in the management of nonalcoholic fatty liver disease
    Amr Dokmak, Mohammad Almeqdadi, Hirsh D. Trivedi, Sandeep Krishnan · 2019 · World Journal of Hepatology
  70. Nonalcoholic fatty liver disease: The hepatic metabolic syndrome
    Jeni Page, ACNP‐BC · 2012 · Journal of the American Academy of Nurse Practitioners
  71. Mechanisms underlying nonalcoholic steatohepatitis
    Manal F. Abdelmalek, Anna Mae Diehl · 2006 · Drug Discovery Today Disease Mechanisms
  72. Plasma Plasminogen Activator Inhibitor-1 Levels and Nonalcoholic Fatty Liver in Individuals With Features of Metabolic Syndrome
    Gabriela Fernanda De Larrañaga, Silvia D. Perés Wingeyer, Mabel Nora Graffigna, Susana Belli, Karla Bendezú, Silvia Alvarez, Oscar A. Levalle, Hugo Alberto Fainboim · 2007 · Clinical and Applied Thrombosis/Hemostasis
  73. The metabolic syndrome: Effects of a pronounced weight loss induced by bariatric surgery
    Julia Engl, Ursula Hanusch‐Enserer, Rudolf Prager, Josef R. Patsch, Christoph F. Ebenbichler · 2005 · Wiener klinische Wochenschrift
  74. Comparative effectiveness of medical treatment vs. metabolic surgery for histologically proven non-alcoholic steatohepatitis and fibrosis: a matched network meta-analysis
    Billeter, Adrian T., Reiners, Beatrice, Seide, Svenja E., Probst, Pascal, Kalkum, Eva, Rupp, Christian, Müller-Stich, Beat P. · 2022 · Hepatobiliary Surgery and Nutrition
  75. TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): A SYSTEMATIC REVIEW
    Layli Eslami, Shahin Merat, S Naseri Moghadam · 2009 · Middle East Journal of Digestive Diseases
  76. Nonalcoholic Fatty Liver Disease in University Rugby Football Players
    Shinsuke Nirengi, Mami Fujibayashi, Sachiko Furuno, Akihiko Uchibe, Yasuharu Kawase, Shin Sukino, Yaeko Kawaguchi, Satomi Minato, Kazuhiko Kotani, Naoki Sakane · 2018 · Frontiers in Endocrinology
  77. The hepatobiliary complications of malnutrition and nutritional support in adults
    Andrew H. McNeice, Ryan Scott, G. Rafferty, William Jonathan Cash, Graham B. Turner · 2018 · Irish Journal of Medical Science (1971 -)
  78. Liver fibrosis alters the molecular structures of hepatic glycogen
    Yujun Wan, Zhenxia Hu, Qinghua Liu, Liang Wang, Mitchell Anthony Sullivan, Robert G. Gilbert · 2021 · Carbohydrate Polymers
  79. Alteration in immune function in patients with fatty liver disease
    Stephanie N. Gregory, Shruthi Reddy Perati, Zachary J. Brown · 2022 · Hepatoma Research
  80. Review: Treatment options for nonalcoholic fatty liver disease
    Shivakumar Chitturi · 2008 · Therapeutic Advances in Gastroenterology
  81. Cardiorespiratory fitness, waist circumference and liver enzyme levels in European adolescents: The HELENA cross-sectional study
    María Medrano, Idoia Labayen, Jonatan R. Ruiz, Gerardo Rodrı́guez, Christina Breidenassel, Manuel J. Castillo, Raquel Pedrero‐Chamizo, Kurt Widhalm, Anthony Kafatos, Yannis Μanios et al. · 2017 · Journal of science and medicine in sport
  82. Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice
    Roberto Rodriguez‐Echevarría, José Macías‐Barragán, Marcela Parra-Vargas, Judith Rebeca Davila-Rodriguez, Eduardo Amezcua-Galvez, Juan Armendáriz‐Borunda · 2018 · World Journal of Gastroenterology
  83. Ameliorative effects of functional crude-chalaza hydrolysates on the hepatosteatosis development induced by a high-fat diet
    Jr‐Wei Chen, Yi‐Ling Lin, Yi‐Hsieng Samuel Wu, Sheng‐Yao Wang, Chung‐Hsi Chou, Yi‐Chen Chen · 2021 · Poultry Science
  84. Pathology of nonalcoholic fatty liver disease
    Ch. Kittas Tiniakos · 2007 · Annals of Gastroenterology
  85. Dendritic Cells in Alcoholic Liver Injury and Fibrosis
    Costica Aloman, Scott L. Friedman, Miriam Mérad · 2011 · Alcoholism Clinical and Experimental Research
  86. The 6th Annual World Congress on the Insulin Resistance Syndrome
    Zachary T. Bloomgarden · 2009 · Diabetes Care
  87. Doença hepática não-alcoólica: evolução após derivação gastrojejunal em Y-de-Roux pela técnica de fobi-capella
    Alexandre Coutinho Teixeira de Freitas, Diane Teixeira de Freitas, Mônica Beatriz Parolin, Antônio Carlos Ligocki Campos, Júlio Cézar Uili Coelho · 2007 · Arquivos de Gastroenterologia
  88. Hepatic Cirrhosis
    Peter Aiden McCormick · 2011
  89. Pepsin-digested chicken-liver hydrolysate attenuates hepatosteatosis by relieving hepatic and peripheral insulin resistance in long-term high-fat dietary habit
    Yi‐Hsieng Samuel Wu, Yi‐Ling Lin, Wen‐Yuan Yang, Sheng‐Yao Wang, Yi‐Chen Chen · 2021 · Journal of Food and Drug Analysis
  90. Foregut bypass vs. restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals
    Wen Hui Lim, Snow Yunni Lin, Cheng Han Ng, Darren Jun Hao Tan, Jieling Xiao, Jie Ning Yong, Phoebe Wen Lin Tay, Nicholas L. X. Syn, Yip Han Chin, Kai En Chan et al. · 2022 · HepatoBiliary Surgery and Nutrition
  91. Disease Progression in a Patient with Nonalcoholic Steatohepatitis
    Ping‐Huei Tseng, Chun‐Jen Liu, Jia‐Horng Kao, Chia‐Tung Shun, Pei‐Jer Chen, Ding‐Shinn Chen · 2008 · Journal of the Formosan Medical Association
  92. Nonalcoholic Fatty Liver Disease
    Melissa Palmer · 2014 · Springer eBooks
  93. Efficacy of Sharapunkhadi powder (a polyherbal formulation) and lifestyle modification in the management of nonalcoholic fatty liver disease-A randomized placebo-controlled clinical trial
    Elavana Remya, Mandip Goyal, Jitendra Nathabhai Varsakiya · 2020 · AYU (An International Quarterly Journal of Research in Ayurveda)
  94. Hypothalamic NPFFR2 attenuates central insulin signaling and its knockout diminishes metabolic dysfunction in mouse models of diabetes mellitus
    Ya‐Tin Lin, Kuan-Hsuan Wu, Jie-Jhu Jhang, Jie-Lan Jhang, Zachary Yu, Sze-Chi Tsai, Jin‐Chung Chen, Po‐Hung Hsu, Hui-Yun Li · 2024 · Clinical Nutrition
  95. Extracellular Vesicles from Mesenchymal Stem Cells: Potential as Therapeutics in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Xue Zou, David R. Brigstock · 2024 · Biomedicines
  96. Comparison of Carotenoids for Their Antifibrogenic Effects in Hepatic Stellate Cells
    Minkyung Bae, Mi‐Bo Kim, Hyunju Kang, Young‐Ki Park, Ji‐Young Lee · 2019 · Lipids
  97. Integrated Analysis of Hepatic miRNA and mRNA Expression Profiles in the Spontaneous Reversal Process of Liver Fibrosis
    Yang Tai, Chong Zhao, Tian Lan, Linhao Zhang, Yang Xiao, Huan Tong, Rui Liu, Chengwei Tang, Jinhang Gao · 2021 · Frontiers in Genetics
  98. Nonalcoholic Fatty Liver Disease
    Henryk Dancygier · 2009 · Springer eBooks
  99. I lexgenin A Obtained from I lex hainanensis Merr. Improves Diet‐Induced Non‐Alcoholic Fatty Liver Disease in Rats
    Wei‐xi Cui, Jingjing Li, Xiao‐qing Chen, Qian Mao, Xiang‐lan Wei, Xiaodong Wen, Jie Yang, Qiang Wang · 2013 · Drug Development Research
  100. Fibrogénesis hepática: fisiopatología
    Gemma Òdena, Ramon A. Bataller · 2012 · Gastroenterología y Hepatología